June 22, 2020 / 1:20 PM / 14 days ago

BRIEF-Cytomx Therapeutics Announces Preclinical Data From Anti-Ctla-4 Probody Therapeutic Programs

June 22 (Reuters) - CytomX Therapeutics Inc:

* CYTOMX THERAPEUTICS ANNOUNCES PRECLINICAL DATA FROM ANTI-CTLA-4 PROBODY THERAPEUTIC PROGRAMS PRESENTED BY PARTNER BRISTOL MYERS SQUIBB AT AACR ANNUAL MEETING Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below